How Malaria Hijacks Your Immune System
Research published last week in PNAS shows that malaria succeeds thanks to a surprising trick. It creates a signaling molecule called a cytokine that disrupts the normal immune system response. This insight could be crucial to developing a cure, and it explains why it often takes a second infection to overwhelm the immune system.
A healthy immune system produces both short-lived and long-lived immune cells. The latter, called memory T cells, sustain an attack after the initial immune response and protect a person when reinfection occurs.
A team lead by researchers at Yale University found that the parasite responsible for malaria creates a signaling molecule that converts long-term memory T cells into short-term immune cells, thereby tipping the balance in favor of the parasite.
The parasite, called plasmodium, is transmitted from one person to another by mosquitoes and lives in the liver before multiplying and circulating in the bloodstream. Malaria infects at least 150 million people per year and kills over half a million people, according to the WHO, and the CDC estimates that half the world’s population is susceptible to the disease.
Keep Reading
Most Popular

Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.

The baby formula shortage has birthed a shady online marketplace
Desperate parents just want to feed their babies. They’re having to contend with misinformation, price gouging, and scams along the way.

I tried to buy an Olive Garden NFT. All I got was heartburn.
Our newest issue spells out what you need to know about the dizzying world of digital money.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.